Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
People with autoimmune conditions or those taking certain medications should also seek professional advice
Research has shown that melanocortin receptor activation promotes glucose uptake in peripheral tissues and enhances lipid mobilization from adipose stores
Moreover, patients with T2DM have impaired incretin action, which highlights GLP-1 as a useful pharmacotherapy for restoring glucose control (reviewed in Madsbad, 2014)
The medication is administered once weekly via subcutaneous injection using a pre-filled pen device, available in doses of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, allowing for gradual dose escalation to optimise tolerability
Thus, activating GLP-1R could also reduce histone lactylation by inhibiting the expression of p300
US$ 20.39
.webp)
US$ 29.02
US$ 28.82
US$ 24.46
